Source:http://linkedlifedata.com/resource/pubmed/id/11149628
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2001-1-8
|
pubmed:abstractText |
Augmented glucose utilisation or secretion of insulin-like-growth-factor II (IGF-II) are discussed as important pathogenetic factors in tumor-associated hypoglycemia (Doege-Potter Syndrome) with suppressed insulin and C-peptide levels. Primary malignant fibrous histiocytoma of the lung is an uncommon neoplasia and its association with hypoglycemia is rare and the causal relationship remains unclear. - We report a 57-year-old male with spontaneous hypoglycemia (1.67 mmol/l) due to a primary malignant fibrous histiocytoma of the lung, secreting IGF-II. Insulin (0.10 nmol/l; normal range 0.33-1.2) and C-peptide (3.0 mIU/l; 5-25) levels were suppressed in combination with low levels of growth hormone (<0.5 ng/ml; <7 ng/ml) and IGF-I (<66.0 ng/ml; 70-246). The elevated IGF-II level (787 ng/ml; 300-500) and decreased IGF-binding protein 3 (1.6 mg/l; 2-5) indicated a high free IGF-II activity. After surgery (resection of the right upper lobe), glucose (4.4 mmol/l), insulin (9.0 mIU/L) and C-peptide (0.84 nmol/l) levels returned to normal. Serum IGF-I (289 ng/ml) and the IGF-I/IGF-II ratio (<0.08 preoperative vs. 0.41 postoperative; >0.20) increased to the normal reference range. - In conclusion, malignant fibrous histiocytoma (MFH) is rarely described presenting as tumor-induced hypoglycemia. Doege-Potter Syndrome in MFH seems to be related to tumor-associated IGF-II production.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor II
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0947-7349
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
515-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11149628-Adult,
pubmed-meshheading:11149628-C-Peptide,
pubmed-meshheading:11149628-Histiocytoma, Benign Fibrous,
pubmed-meshheading:11149628-Human Growth Hormone,
pubmed-meshheading:11149628-Humans,
pubmed-meshheading:11149628-Hypoglycemia,
pubmed-meshheading:11149628-Insulin,
pubmed-meshheading:11149628-Insulin-Like Growth Factor I,
pubmed-meshheading:11149628-Insulin-Like Growth Factor II,
pubmed-meshheading:11149628-Lung Neoplasms,
pubmed-meshheading:11149628-Male,
pubmed-meshheading:11149628-Tomography, X-Ray Computed
|
pubmed:year |
2000
|
pubmed:articleTitle |
Primary malignant fibrous histiocytoma of the lung: IGF-II producing tumor induces fasting hypoglycemia.
|
pubmed:affiliation |
Department of Medicine, University of Essen, Germany. burkhard.hermann@uni-essen.de
|
pubmed:publicationType |
Journal Article,
Case Reports
|